Program Co-Director, John Gordon, MD is a cardiologist with the San Diego Cardiac Center. He has been hosting the Maui Cardiovascular Symposium since 2007. His goal is to bring together the best and brightest in the field of cardiovascular disease in order to expand knowledge, treatment, and education in the field.


Program Co-Director, Richard Wright, MD is a cardiologist with the Pacific Heart Institute.  He is supporting with designing a hybrid symposium and directing a new Heart Failure session presented by medical experts.

TARGET AUDIENCE: Cardiologists, electrophysiologists, cardiovascular surgeons, interventional radiologists, and other healthcare professionals with an interest in the treatment of cardiovascular diseases.

Accreditation with Commendation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Swedish Medical Center and Providence St. Joseph Health. Swedish Medical Center is accredited by the ACCME to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™
Swedish Medical Center designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.


At the conclusion of this course, the participant will provide better patient care through an increased ability to:
• Apply the recent interventional, pharmacological, device-based surgical advances in the treatment and management of cardiac arrhythmias, advanced heart failure and cardiogenic
shock, cardiac transplantation, peripheral arterial disease, pulmonary hypertension, aneurysmal disease, and pulmonary embolism
• Utilize new medications and imaging modalities in the screening and management of ischemia, coronary artery disease, sleep apnea, and hyperlipidemia
• Define evolving role of the cardiologist in the treatment of heart failure, hyperlipidemia, diabetes, cardiovascular disease in women, and use of artificial intelligence
• Discuss recent advances in medical, surgical, and percutaneous treatment for management of hypertension, PFO closure, left atrial occlusion, valvular heart disease, vascular disease, and Kawasaki disease
• Apply new and updated recommendations for professionalism and ethics in cardiology